Pharmas Spar Over Plant-Based Mood Enhancer

Law360, New York (August 10, 2007, 12:00 AM EDT) -- Unigen Pharmaceuticals Inc., which develops natural, plant-derived products, has been hit with a lawsuit accusing it of infringing a patent and a trademark on the ingredient Seroctin.

In a complaint filed Thursday with the U.S. District Court for the District of Utah, Seroctin Research & Technologies Inc. alleged that Unigen and its affiliate Univera Life Sciences broke a license and exclusive supply agreement between the parties.

They then allegedly violated the patent and the trademark by continuing to sell Seroctin, which is supposed to improve sleep,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.